UBE2C and Familial prostate cancer: Interestingly, the manipulation of miRNAs, namely miR661-3p and miR-381-3p, has shown the ability to target UBE2C in NSCLC and prostate cancer cells, respectively, leading to reduced proliferation, invasion, and metastasis [120,121].